How many reps now?

























WASHINGTON (MarketWatch) — Among the stocks that could see active trade in Friday’s session are Novartis AG, Metabolix Inc. and JDA Software Group Inc. NVS -1.52%

Novartis NVS -1.52% *said it will cut 1,960 jobs, primarily from the ranks of its U.S. sales operations, in a restructuring precipitated by generic competition expected to emerge for its heart drug Diovan. Staff reductions will become effective starting in the second quarter. Management’s expectations for lower potential sales from high-blood pressure medicine Rasilez will mean taking a charge of $900 million against results for the fourth quarter of 2011, with discontinuation of two experimental drugs to be covered by a one-time charge of $160 million. Novartis will also take a restructuring-related charge of $160 million against first-quarter results. The restructuring’s likely to lead to savings of about $450 million a year by 2013, Novartis said.